0001209191-20-003247.txt : 20200113
0001209191-20-003247.hdr.sgml : 20200113
20200113200649
ACCESSION NUMBER: 0001209191-20-003247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200112
FILED AS OF DATE: 20200113
DATE AS OF CHANGE: 20200113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fowler John Franklin
CENTRAL INDEX KEY: 0001744263
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 20524777
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-12
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001744263
Fowler John Franklin
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
CEO
Employee Stock Option (right to buy)
3.29
2020-01-12
4
A
0
200000
0.00
A
2030-01-11
Common Stock
200000
200000
D
One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 1, 2020, subject to the Reporting Person continuing to provide service through each such date.
/s/ Marc Belsky, Attorney-in-Fact
2020-01-13